A Pilot Study of HP802-247 in Dystrophic Epidermolysis Bullosa
NCT01528306
·
clinicaltrials.gov ↗
PHASE2
Phase
WITHDRAWN
Status
INDUSTRY
Sponsor class
Conditions
Dystrophic Epidermolysis Bullosa
Interventions
BIOLOGICAL:
HP802-247
OTHER:
Placebo
Sponsor
Healthpoint